Dubai PR Network, Online Press Release from Dubai and Middle East
 
Health & Fitness(Healthcare & Medicine)
Filter PR by
  

New study finds triple-negative breast cancer tumors with an increase in immune cells have lower risk of recurrence after surgery – even when not treated with chemotherapy

 
New study finds triple-negative breast cancer tumors with an increase in immune cells have lower risk of recurrence after surgery – even when not treated with chemotherapy

ROCHESTER, Minn. — A new multicenter, international study suggests that people who have early-stage triple-negative breast cancer (TNBC) and high levels of immune cells within their tumors may have a lower risk of recurrence and better survival rates even when not treated with chemotherapy. The study was published today in the Journal of American Medical Association (JAMA).

TNBC is a breast cancer subtype that does not respond to drugs that target the estrogen receptor or the HER2 protein. It grows rapidly, is more likely to spread beyond the breast before diagnosis and is more likely to recur than other breast cancers. TNBC represents about 15% of all breast cancers and is more common in younger people and in women of African American, Hispanic and Indian descent. Immune cells, also known as tumor-infiltrating lymphocytes, or TILs, are naturally existing immune system cells that can move from the bloodstream into a tumor and can recognize and destroy cancer cells. 

'This is an important finding because it highlights that the abundance of TILs in breast tissue is a prognostic biomarker in people with early-stage triple-negative breast cancer, even when chemotherapy is not administered,' says Roberto Leon-Ferre, M.D., a breast medical oncologist at Mayo Clinic Comprehensive Cancer Center and first author of the study. 'The study's findings may inspire future clinical trials to explore whether patients with a favorable prognosis (high TILs) can avoid intensive chemotherapy regimens.'

'This meta-analysis confirms robustly the prognostic value of TILs that we have previously reported in TNBC patients treated with chemotherapy and expands it to patients treated without chemotherapy,' says Sarah Flora Jonas, Ph.D., a statistician at Gustave Roussy and co-first author of the study. 'Future studies may allow the use of this biomarker along with standard clinicopathological factors to inform treatment decisions in TNBC patients.' 

'Of interest, the first report suggesting that an increased number of immune cells being associated with better prognosis in breast cancer patients was described by doctors at Mayo Clinic more than 100 years ago,' says Roberto Salgado, M.D., co-chair of the International Immuno-Oncology Biomarker Working Group and co-lead of the study. 'It took a global effort and a century later to reexamine this biomarker and bring it closer to application in patient care.' 

'TILs are not currently measured or reported in the routine examination of tissue samples of breast cancer,' says co-senior author, Matthew Goetz, M.D., a medical oncologist at Mayo Clinic Comprehensive Cancer Center and the Erivan K. Haub Family Professor of Cancer Research Honoring Richard F. Emslander, M.D. 'While prior studies have focused on measuring TILs in people treated with chemotherapy, this is the largest study to comprehensively demonstrate that the presence of TILs influences the natural behavior of breast cancer in people who have surgery and/or radiation with no additional medical treatment.'

For this study, Mayo Clinic and Gustave Roussy researchers, in collaboration with the International Immuno-Oncology Biomarker Working Group, led 11 additional groups to collect data on 1,966 participants with early-stage TNBC who only underwent surgery with or without radiation therapy but did not receive chemotherapy. The participants had been followed for a median of 18 years. The results showed that higher levels of TILs in breast cancer tissue were associated with lower recurrence rates among participants with early-stage TNBC. 

'Five years after surgery, 95% of participants with small tumors, stage 1 TNBC, and whose tumors had high TILs were alive, compared to 82% of patients whose tumors had low TILs. Importantly, the breast cancer recurrence rate was significantly lower among patients whose tumors had high TILs,' says co-senior author, Stefan Michiels, Ph.D., head of Oncostat team, Gustave Roussy, Inserm U1018, University Paris-Saclay. 'With nearly 2,000 participants involved in the study, we have now assembled the largest international cohort across three continents of people with TNBC in which the primary treatment was surgery without chemotherapy.'

'The results of this study could lead to a recommendation to include TILs in the pathology reports of early-stage TNBC worldwide, as it has the potential to inform clinicians and patients when they discuss treatment options,' says Dr. Salgado. 

Furthermore, this biomarker would only require a visual evaluation by a pathologist looking through a microscope, meaning there are no additional costs associated with identifying the presence of immune cells. This could be particularly beneficial to regions with limited resources, adds Dr. Leon-Ferre. 

Most people with early-stage TNBC undergo chemotherapy either before or after surgery, including people with stage 1 breast cancer. Most people receive multiple chemotherapy drugs in combination, which can cause significant side effects. Currently, the main factors taken into consideration to determine the course of chemotherapy treatment for each person are the tumor size and the presence of lymph node metastases. However, the authors identified that the number of TILs further influences the risk of future recurrence.

The researchers plan to evaluate TILs as biomarkers in prospective clinical trials evaluating chemotherapy selection based on TIL levels. Ongoing efforts to conduct additional research with other potential biomarkers are underway.


Posted by : DubaiPRNetwork.com Editorial Team
Viewed 8216 times
PR Category : Healthcare & Medicine
Posted on : Monday, April 22, 2024  10:42:00 AM UAE local time (GMT+4)
Replication or redistribution in whole or in part is expressly prohibited without the prior written consent of DubaiPRNetwork.com.
Previous Story : Eight-year-old Emirati finds voice for first time after unde...
Next Story : Cleveland Clinic Gastroenterologist Shares Risk-Reduction an...
Email this article Print this article

Share this article with your friends and followers
NewsVine
 
 
Most Viewed Press Release posted in the last 7 days
Hunger Hotspots Report: Famine Looms In Gaza While Risk Of Starvation Persists In Sudan, H... [41258-Views]
Urgent Call To Action To Address Historic El Niño Drought In Southern Africa [40914-Views]
Cathay Pacific to launch direct flights connecting Hong Kong and Riyadh [29655-Views]
Last-Minute Eid Shopping With Max Fashion's New Collection [9422-Views]
Emirates scores 3 top awards for Inflight Entertainment, Connectivity, and Premium Economy... [9172-Views]
Living Proof® Brings Its Pioneering, Science-Backed Haircare Solutions To The Region [8307-Views]
REDTAG Presents a Range of Captivating Styles with its Eid Al Adha Collection 2024 [8286-Views]
SHREE Unveils New Store in Dubai Silicon Central, Bringing Contemporary Fashion to the Hea... [8200-Views]
Eid Al-Adha Gifting with Lush Middle East | Eid Exclusives, Haircare Sets and Spa Treatmen... [7983-Views]
Danube Group Onboards Dubai Media Inc. as Their Official Media Partner [7798-Views]
ADFD and AIIB host knowledge exchange workshop, Paving way for enhanced climate action ini... [7728-Views]
LINDBERG Sun Titanium: Impossibly Lightweight [7585-Views]
Spin, Win & Celebrate! Deerfields Mall gears up for Eid al Adha [7216-Views]
SharkNinja Makes Waves in Dubai with First-Ever Middle East Showcase and Regional Launch o... [6896-Views]
Introducing the LUSH Spa: A Sanctuary for Self-Care and Holistic Wellbeing [6863-Views]
Yates takes lead at Tour de Suisse summit finish [6826-Views]
Meet Your Hair Care Match With Lush's New Gift Sets [6822-Views]
Abu Dhabi University Climbs 79 places in the 2025 QS World University Rankings [6646-Views]
Dubai SME and Danube Group Sign Cooperation Agreement to Boost Market Opportunities and Fo... [6585-Views]
2024 marks a break through for sustainability in the GCC, PwC report [6539-Views]
Economic Integration Committee reviews progress of National Registry, discusses UAE's ende... [6539-Views]
Celebrate kindness and joy with Lush's festive Eid collection [6503-Views]
LG Delivers Sensational Summer Vibes Through Soundbar's Spatial Sound Technology [6330-Views]
EarthSoul celebrates World Environment Day with expert panel on environmental stewardship [6310-Views]
Savanna Presents Their Conscious Capsule Collection: Back To Roots: Edition 1 [6261-Views]
 
RSS Facebook Twitter LinkedDin DubaiPRNetwork.com on Instagram
Back to Section Home

Related Stories

 
Top Sections
 
Top Stories